HYDROXYPROGESTRONE CAPROATE 250 MG INJECTION

BRAND NAME-WISEFEO-250 INJECTION

COMPOSITION: HYDROXYPROGESTRONE CAPROATE 250 MG INJECTION

PACKING: SINGLE INJECTION (COMBIPACK)

HYDROXYPROGESTRONE

Wisefeo-250 injection (Hydroxyprogesterone Caproate Injection USP) is a sterile, long-acting preparation of the caproate ester of the aturallyoccurring progestational hormone, hydroxyprogesterone, in an oil solution for intramuscular use.

Hydroxyprogesterone is a potent, long-acting, progestational steroid ester which transforms proliferative endothelium into
secretory endothelium, induces mammary gland duct development, and inhibits the production and/or release of onadotropic hormone; it also shows slight estrogenic, androgenic, or corticoid effects as well, but should not be relied upon for these effects.

  • -Administer wisefeo-250 injection intramuscularly at a dose of 250 mg (1 mL) once weekly.
  • – Begin treatment between 16 weeks, 0 days and 20 weeks, 6 days of gestation.
  • – Continue administration of wisefeo-250 injection once weekly until week 37 (through 36 weeks, 6 days) of gestation or delivery, whichever occurs first.

INDICATIONS OF WISEFEO-250 INJECTION

1.Amenorrhea.

2.Prevention of preterm labour.

3.Dysfunctional uterine bleeding.

4.Advanced uterine cancer.

Leave a Comment